We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Publishes New Guidance on Rheumatoid Arthritis Drug Trials
EMA Publishes New Guidance on Rheumatoid Arthritis Drug Trials
The European Medicines Agency updated guidance on clinical investigations of rheumatoid arthritis drugs to add new endpoints and distinguish between patient subgroups in trials.